Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2013Science Translational Medicine

Vaccine Economics: What Price Human Life?

View Full Paper
Ask AI
Bookmark
Share

Authors

John J. MekalanosJohn J. MekalanosUniversity of California, Riverside

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

John J. Mekalanos (2013) studied this question.

synapsesocial.com/papers/6ab1ec177ce4953273efc98dhttps://doi.org/10.1126/scitranslmed.3007588
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The role of health economic analyses in vaccine decision making2013 · 43 citations
  2. 2Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young Children2000 · 281 citations
  3. 3Cost-Effectiveness of Pneumococcal Conjugate Vaccine2006 · 162 citations
  4. 4Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998 Opportunities for Prevention in the Conjugate Vaccine Era2001 · 656 citations
  5. 5Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis2004 · 713 citations